A talented drama student left bed bound and struggling to talk by a rare liver disease is being helped by researchers at Royal Surrey County Hospital.
Emma Gaul was forced to put her plans for drama school on hold when she was diagnosed with Wilson’s disease, a genetic disorder which causes a toxic overload of copper in the body.
The illness progressed rapidly and left the teenager with neurological difficulties and cirrhosis of the liver, which is more commonly associated with people who drink too much alcohol.
The teenager from Warrenpoint, Northern Ireland, is now the first patient taking part in a clinical trial at Royal Surrey County Hospital.
The Trust is one of two sites in the UK that has been chosen to trial the new drug, bis-chloline Tetrathiomolybdate (WTX101), with Professor Aftab Ala chosen as the principle investigator.